Neurotrophin-Induced Migration and Neuronal Differentiation of Multipotent Astrocytic Stem Cells In Vitro
Open Access
- 12 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12) , e51706
Abstract
Hypoxic ischemic encephalopathy (HIE) affects 2–3 per 1000 full-term neonates. Up to 75% of newborns with severe HIE die or have severe neurological handicaps. Stem cell therapy offers the potential to replace HIE-damaged cells and enhances the autoregeneration process. Our laboratory implanted Multipotent Astrocytic Stem Cells (MASCs) into a neonatal rat model of hypoxia-ischemia (HI) and demonstrated that MASCs move to areas of injury in the cortex and hippocampus. However, only a small proportion of the implanted MASCs differentiated into neurons. MASCs injected into control pups did not move into the cortex or differentiate into neurons. We do not know the mechanism by which the MASCs moved from the site of injection to the injured cortex. We found neurotrophins present after the hypoxic-ischemic milieu and hypothesized that neurotrophins could enhance the migration and differentiation of MASCs. Using a Boyden chamber device, we demonstrated that neurotrophins potentiate the in vitro migration of stem cells. NGF, GDNF, BDNF and NT-3 increased stem cell migration when compared to a chemokinesis control. Also, MASCs had increased differentiation toward neuronal phenotypes when these neurotrophins were added to MASC culture tissue. Due to this finding, we believed neurotrophins could guide migration and differentiation of stem cell transplants after brain injury.Keywords
This publication has 64 references indexed in Scilit:
- Protoplasmic Astrocytes Enhance the Ability of Neural Stem Cells to Differentiate into Neurons In VitroPLOS ONE, 2012
- Circulating and Brain BDNF Levels in Stroke Rats. Relevance to Clinical StudiesPLOS ONE, 2011
- Effect of NRG1, GDNF, EGF and NGF in the Migration of a Schwann Cell Precursor LineNeurochemical Research, 2010
- The effect of the dosage of NT-3/chitosan carriers on the proliferation and differentiation of neural stem cellsBiomaterials, 2010
- Brain‐derived neurotrophic factor and the development of structural neuronal connectivityDevelopmental Neurobiology, 2010
- Delayed neural network degeneration after neonatal hypoxia‐ischemiaAnnals of Neurology, 2008
- GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALSPLOS ONE, 2007
- Treatment of hypoxic–ischemic encephalopathy in mouse by transplantation of embryonic stem cell-derived cellsNeurochemistry International, 2007
- Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic–ischemic brain injuryExperimental Neurology, 2006
- GDNF is a chemoattractant factor for neuronal precursor cells in the rostral migratory streamMolecular and Cellular Neuroscience, 2006